Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 14, 2014 - Issue 6
Submit an article Journal homepage
721
Views
18
CrossRef citations to date
0
Altmetric
Drug Evaluations

Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence

Arrigo FG CiceroS. Orsola-Malpighi University Hospital, Medical and Surgical Sciences Department, Internal Medicine Unit, Pad. 2, Via Albertoni 15, 40138 Bologna, Italy+39 3498558017; +39 0516826125; [email protected], [email protected]
, MD PhD,
Elisa TartagniBologna University, Medical and Surgical Sciences Department, Internal Medicine Unit, Bologna, Italy
, MD &
Sibel ErtekAnkara Koru Hospital, Department of Endocrinology and Metabolic Diseases, Balgat- Ankara, Turkey
, MD PhD
Pages 863-868 | Published online: 24 Mar 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.